Efficacy and safety of zoledronic acid in the treatment of bone metastases associated with lung cancer and other solid tumors

被引：23
作者：
Rosen, LS [1 ]
机构：
[1] Canc Inst Med Grp, Dev Therapeut, Santa Monica, CA 90404 USA
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 06期
关键词：
D O I：
10.1053/sonc.2002.37416
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：28 / 32
页数：5
相关论文
共 53 条
  • [1] DICHLOROMETHYLENE-DIPHOSPHONATE IN PATIENTS WITH PROSTATIC-CARCINOMA METASTATIC TO THE SKELETON
    ADAMI, S
    SALVAGNO, G
    GUARRERA, G
    BIANCHI, G
    DORIZZI, R
    ROSINI, S
    MOBILIO, G
    LOCASCIO, V
    [J]. JOURNAL OF UROLOGY, 1985, 134 (06) : 1152 - 1154
  • [2] Adami S, 1989, Recent Results Cancer Res, V116, P67
  • [3] Berenson JR, 2001, CANCER, V91, P1191, DOI 10.1002/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO
  • [4] 2-0
  • [5] Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma
    Berenson, JR
    Lichtenstein, A
    Porter, L
    Dimopoulos, MA
    Bordoni, R
    George, S
    Lipton, A
    Keller, A
    Ballester, O
    Kovacs, MJ
    Blacklock, HA
    Bell, R
    Simeone, J
    Reitsma, DJ
    Heffernan, M
    Seaman, J
    Knight, RD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) : 488 - 493
  • [6] Current use of bisphosphonates in oncology
    Body, JJ
    Bartl, R
    Burckhardt, P
    Delmas, PD
    Diel, IJ
    Fleisch, H
    Kanis, JA
    Kyle, RA
    Mundy, GR
    Paterson, AHG
    Rubens, RD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) : 3890 - 3899
  • [7] Boissier S, 2000, CANCER RES, V60, P2949
  • [8] Should bisphosphonates be the treatment of choice for metastatic bone disease?
    Coleman, RE
    [J]. SEMINARS IN ONCOLOGY, 2001, 28 (04) : 35 - 41
  • [9] Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.3.CO
  • [10] 2-Z
123456